News
age-related macular degeneration
Macular Degeneration | Hard versus Soft Drusen
Drusen can be either hard or soft and while both types need to be monitored, hard drusen don't usually cause vision problems.
AMD
Parkinson's drug may be a treatment for advanced age-related macular degeneration
Researchers discovered that levodopa is safe, well-tolerated and not only improved visual outcomes but also delayed anti-VEGF injections.
cardiovascular health
A healthy heart can help keep your eyes healthy
Researchers analyzed the data from 6,118 adults who were 40 years old or older and had participated in the National Health and Nutrition Examination Survey between the years of 2005 - 2008.
declining vision
Seeing red: How red light therapy may help declining vision
Researchers at the University College London are looking into the possible benefits of red light therapy for people suffering from declining vision.
age-related macular degeneration
New technology detects Macular Degeneration
Researchers from the New York Eye and Ear Infirmary of Mount Sinai announced results of a study that analyzed the speed and accuracy of a new artificial intelligence (AI) algorithm in detecting ag...
blindness
VisiVite Subscribers Asked about Fear of Blindness
On June 17, 2020, VisiVite subscribers were sent the email below and asked to complete a two-question survey about their fear of blindness. Their responses will be posted here.
age-related macular degeneration
New device provides early detection of macular degeneration
The new technology will be helpful in providing an earlier diagnosis of age-related macular degeneration.
age-related macular degeneration
Repeated anti-VEGF injections may increase glaucoma risk
Researchers found an increased risk for the development of ocular hypertension and glaucoma with frequent anti-VEGF injections over a 6-month period.
age-related macular degeneration
Wet and Dry Macular Degeneration share common link
Researchers have discovered that wet and dry macular degeneration both lack the same enzyme.